The impact of the Glasgow Prognostic Score on survival in second-line chemotherapy for metastatic colorectal cancer patients with BRAF V600E mutation

BACKGROUND: BRAF (v-raf murine sarcoma viral oncogene homolog B1) V600E mutant colorectal cancer is associated with short survival. Recently, clinical trials have been conducted to improve outcomes of second or later lines of chemotherapy. However, there is a paucity of reference data pertaining to...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ther Adv Med Oncol
Asıl Yazarlar: Mitani, Seiichiro, Taniguchi, Hiroya, Sugiyama, Keiji, Masuishi, Toshiki, Honda, Kazunori, Narita, Yukiya, Kadowaki, Shigenori, Ura, Takashi, Ando, Masashi, Tajika, Masahiro, Yatabe, Yasushi, Muro, Kei
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: SAGE Publications 2019
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6348546/
https://ncbi.nlm.nih.gov/pubmed/30719102
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835918820298
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller